Page 1 of Clinical Trials for Drug Rivastigmine Transdermal Patch, 29 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: September 27, 2011
Condition(s): Alzheimer's Disease
2
Active, not recruiting
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease
3
Completed
An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease
4
Completed
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Last Updated: May 4, 2012
Condition(s): Alzheimer's Disease
5
Not yet recruiting
Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Last Updated: March 5, 2012
Condition(s): Alzheimer's Disease
6
Completed
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Last Updated: October 19, 2011
Condition(s): Parkinson's Disease Dementia
7
Completed
Exelon Patch and Combination With Memantine Comparative Trial
Last Updated: May 18, 2010
Condition(s): Alzheimer's Disease
8
Enrolling by invitation
A 24 Week Open-Label Extension to Study CENA713DUS44
Last Updated: November 22, 2011
Condition(s): Alzheimer's Disease
9
Recruiting
Rivastigmine in the Management of Delirium
Last Updated: December 6, 2011
Condition(s): Delirium
10
Terminated
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Last Updated: March 8, 2012
Condition(s): Multiple Sclerosis; Cognitive Impairment
11
Completed
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Last Updated: July 21, 2011
Condition(s): Alzheimer Disease
12
Completed
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: February 24, 2011
Condition(s): Alzheimer's Disease
13
Completed
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Last Updated: December 17, 2007
Condition(s): Alzheimer's Disease; Dementia, Alzheimer Type
14
Completed
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Last Updated: June 27, 2011
Condition(s): Alzheimer's Disease
15
Completed
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
Last Updated: March 19, 2012
Condition(s): Alzheimer Disease
16
Recruiting
Mild Cognitive Impairment in Parkinson's Disease
Last Updated: January 23, 2012
Condition(s): Parkinson's Disease; Mild Cognitive Impairment
17
Completed
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Last Updated: May 15, 2012
Condition(s): Alzheimer's Disease
18
Not yet recruiting
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Last Updated: April 24, 2012
Condition(s): Alzheimer's Dementia
19
Completed
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Last Updated: May 27, 2011
Condition(s): Alzheimer's Disease
20
Recruiting
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Last Updated: April 24, 2012
Condition(s): Alzheimer's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Rivastigmine+Transdermal+Patch

Page 1 of Clinical Trials for Drug Rivastigmine Transdermal Patch, 29 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About